Mukta Basu

Employment

• The University of Texas MD Anderson Cancer Center Postdoctoral Fellow
  2025 - Present
• Cedars-Sinai Medical Center Postdoctoral Scientist
  2022 - 2025
• Chittaranjan National Cancer Institute RESEARCH FELLOW
  2015 - 2020

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (7)

• Genes driving three-dimensional growth of immortalized cells and cancer.
  Cell death & disease 2025 2 citations DOI: 10.1038/s41419-025-07719-5
  +Save
• Concurrent loss of the Y chromosome in cancer and T cells impacts outcome.
  Nature 2025 42 citations DOI: 10.1038/s41586-025-09071-2
  +Save
• Arsenic level in bladder tumor of patients from an exposed population: association with progression and prognosis
  Future Oncology 2021 12 citations DOI: 10.2217/fon-2020-0154
  +Save
• Differential Wnt-β- catenin pathway activation in HPV positive and negative oral epithelium is transmitted during head and neck tumorigenesis: clinical implications
  Medical Microbiology and Immunology 2021 14 citations DOI: 10.1007/s00430-020-00697-9
  +Save
• Integrative genomics and pathway analysis identified prevalent FA-BRCA pathway alterations in arsenic-associated urinary bladder carcinoma: Chronic arsenic accumulation in cancer tissues hampers the FA-BRCA pathway
  Genomics 2020 19 citations DOI: 10.1016/j.ygeno.2020.09.012
  +Save
• Reduction of nuclear Y654‐p‐β‐catenin expression through SH3GL2‐meditated downregulation of EGFR in chemotolerance TNBC: Clinical and prognostic importance
  Journal of Cellular Physiology 2020 9 citations DOI: 10.1002/jcp.29466
  +Save
• Downregulation of beta-catenin in chemo-tolerant TNBC through changes in receptor and antagonist profiles of the WNT pathway: Clinical and prognostic implications
  Cellular Oncology 2020 13 citations DOI: 10.1007/s13402-020-00525-5
  +Save